What is the recommended management for a 17 mm low‑attenuation left adnexal mass in an 80‑year‑old woman?

Differential Diagnosis and Management of 17 mm Low-Attenuation Left Adnexal Mass in an 80-Year-Old Woman

Primary Recommendation

Perform transvaginal ultrasound with transabdominal ultrasound as the next diagnostic step to characterize this mass, as CT is inadequate for definitive characterization of adnexal lesions. 1

Diagnostic Approach

Why Ultrasound is Essential

• CT has limited utility for adnexal mass characterization in the absence of acute symptoms, as the roles of ultrasound and MRI are well-established for this purpose 1
• Transvaginal ultrasound combined with transabdominal technique is the most useful modality for evaluating adnexal masses, allowing detailed assessment of features relevant for malignancy risk stratification 1
• The ultrasound should specifically evaluate: size, locularity, presence of solid components, septation thickness, excrescences, internal vascularity on color Doppler, and ascites 1, 2

Differential Diagnosis Based on "Low Attenuation" Finding

A 17 mm low-attenuation mass on CT suggests a cystic or fluid-filled lesion. In an 80-year-old postmenopausal woman, the differential includes:

• Simple cyst (most likely if truly anechoic on ultrasound)
• Cystadenoma (serous or mucinous)
• Paraovarian cyst
• Hydrosalpinx
• Early malignancy (cannot be excluded without proper characterization)

Risk Stratification After Ultrasound

If Confirmed as Simple Cyst on Ultrasound

• Simple cysts ≤3 cm in postmenopausal women require no further management 3
• For this 17 mm (1.7 cm) simple cyst, no follow-up is needed as the malignancy risk is essentially zero (0-0.5 cases per 10,000 women over 3 years) 1, 3
• Simple cysts up to 10 cm can be safely monitored without surgical intervention in postmenopausal patients when evaluated by experienced ultrasonographers 3

If Complex Features Present on Ultrasound

Refer to gynecologic oncology if any high-risk features are identified: 4, 5

• Solid components or nodularity
• Thick septations (>3 mm)
• Increased vascularity on color Doppler
• Ascites
• Bilateral masses
• Size >10 cm

O-RADS Classification System

• Use the O-RADS US risk stratification system to categorize malignancy risk, which demonstrates 96.8% sensitivity for malignancy 1
• This standardized reporting enables clear communication with gynecologists regarding management decisions 6

Management Algorithm

For Benign-Appearing Masses (O-RADS 1-2)

Simple cysts ≤3 cm: No follow-up required 3

Simple cysts 3-10 cm:

• Recommend at least 1-year follow-up ultrasound showing stability or decrease 3
• Consider annual follow-up for up to 5 years if stable 3
• After 12 months of demonstrated stability, the benefit of continued imaging is minimal and may be outweighed by risks of repeated imaging 7

For Indeterminate Masses

• MRI pelvis with and without IV contrast is the alternative imaging modality if ultrasound characterization is inadequate 1
• Contrast-enhanced MRI is superior to both ultrasound and noncontrast MRI for detecting internal enhancing soft tissue components 1

When to Stop Surveillance

Critical finding: In patients ≥50 years with stable adnexal masses, no ovarian cancers were detected after 52 weeks of stability in a large community-based study of 4,061 patients 7

• The absolute ovarian cancer risk with stable masses was only 0.27% overall 7
• Risk progressively declined: 0.73 per 1,000 person-years at 6-12 weeks to 0.00 after 52 weeks 7

Common Pitfalls to Avoid

• Do not rely on CT alone for adnexal mass characterization—it cannot adequately assess internal architecture, septations, or vascularity 1
• Do not assume all postmenopausal cysts require surgery—the vast majority of simple cysts are benign even in this age group 3
• Do not order CA-125 before ultrasound characterization—it should be reserved for masses with concerning ultrasound features 4, 2
• Avoid indefinite surveillance of truly stable benign-appearing masses beyond 12 months, as the yield is extremely low 7

Immediate Action Required

Order transvaginal and transabdominal pelvic ultrasound with color Doppler to properly characterize this mass before any management decisions 1